Integrative functional genomic analysis of intron retention in human and mouse brain with Alzheimer's disease
Hong-Dong Li,Cory C. Funk,Karen McFarland,Eric B. Dammer,Mariet Allen,Minerva M. Carrasquillo,Yona Levites,Paramita Chakrabarty,Jeremy D. Burgess,Xue Wang,Dennis Dickson,Nicholas T. Seyfried,Duc M. Duong,James J. Lah,Steven G. Younkin,Allan Levey,Gilbert S. Omenn,Nilufer Ertekin-Taner,Todd E. Golde,Nathan D. Price
DOI: https://doi.org/10.1002/alz.12254
2021-01-01
Alzheimer s & Dementia
Abstract:Intron retention (IR) has been implicated in the pathogenesis of complex diseases such as cancers; its association with Alzheimer's disease (AD) remains unexplored. We performed genome-wide analysis of IR through integrating genetic, transcriptomic, and proteomic data of AD subjects and mouse models from the Accelerating Medicines Partnership-Alzheimer's Disease project. We identified 4535 and 4086 IR events in 2173 human and 1736 mouse genes, respectively. Quantitation of IR enabled the identification of differentially expressed genes that conventional exon-level approaches did not reveal. There were significant correlations of intron expression within innate immune genes, like HMBOX1, with AD in humans. Peptides with a high probability of translation from intron-retained mRNAs were identified using mass spectrometry. Further, we established AD-specific intron expression Quantitative Trait Loci, and identified splicing-related genes that may regulate IR. Our analysis provides a novel resource for the search for new AD biomarkers and pathological mechanisms.